William R. Gillespie

3.0k total citations · 1 hit paper
65 papers, 2.2k citations indexed

About

William R. Gillespie is a scholar working on Spectroscopy, Oncology and Pharmacology. According to data from OpenAlex, William R. Gillespie has authored 65 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Spectroscopy, 11 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in William R. Gillespie's work include Analytical Chemistry and Chromatography (13 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Drug Solubulity and Delivery Systems (9 papers). William R. Gillespie is often cited by papers focused on Analytical Chemistry and Chromatography (13 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Drug Solubulity and Delivery Systems (9 papers). William R. Gillespie collaborates with scholars based in United States, United Kingdom and Germany. William R. Gillespie's co-authors include Peter Veng‐Pedersen, R.J. Prescott, Adrian Grant, Carl Counsell, Sue Ross, Ian Russell, Kenneth S. Albert, John G. Wagner, Christian P. Whitman and Neal J. Stolowich and has published in prestigious journals such as Journal of the American Chemical Society, Blood and The American Journal of Medicine.

In The Last Decade

William R. Gillespie

64 papers receiving 2.1k citations

Hit Papers

Barriers to Participation... 1999 2026 2008 2017 1999 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Barriers to Participation in Randomised Controlled Trials
    1999 712 citations Sue Ross, Adrian Grant et al. Journal of Clinical Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William R. Gillespie United States 25 527 325 301 294 273 65 2.2k
Thomas M. Ludden United States 32 228 0.4× 612 1.9× 687 2.3× 142 0.5× 167 0.6× 158 4.1k
Mathiéu Molimard France 47 398 0.8× 437 1.3× 234 0.8× 211 0.7× 202 0.7× 250 7.9k
G. Russell Warnick United States 40 1.0k 1.9× 425 1.3× 187 0.6× 259 0.9× 97 0.4× 88 9.5k
James M Wright Canada 47 403 0.8× 423 1.3× 651 2.2× 590 2.0× 55 0.2× 166 5.9k
Graham Jones Australia 31 271 0.5× 293 0.9× 100 0.3× 128 0.4× 66 0.2× 151 4.1k
Stuart Walker United Kingdom 29 338 0.6× 132 0.4× 203 0.7× 894 3.0× 48 0.2× 183 3.2k
Linda M. Thienpont Belgium 38 300 0.6× 146 0.4× 138 0.5× 69 0.2× 527 1.9× 146 5.7k
Peter H. Vlasses United States 28 323 0.6× 359 1.1× 261 0.9× 185 0.6× 59 0.2× 176 2.9k
Richard M. Turner United Kingdom 25 394 0.7× 97 0.3× 286 1.0× 102 0.3× 100 0.4× 58 2.1k
S. George Carruthers Canada 29 424 0.8× 945 2.9× 198 0.7× 327 1.1× 39 0.1× 77 6.4k

Countries citing papers authored by William R. Gillespie

Since Specialization
Citations

This map shows the geographic impact of William R. Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Gillespie more than expected).

Fields of papers citing papers by William R. Gillespie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Gillespie. The network helps show where William R. Gillespie may publish in the future.

Co-authorship network of co-authors of William R. Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Gillespie. A scholar is included among the top collaborators of William R. Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Gillespie. William R. Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mondick, John, et al.. (2023). Bayesian estimation in NONMEM. CPT Pharmacometrics & Systems Pharmacology. 13(2). 192–207. 7 indexed citations
2.
Goteti, Kosalaram, William R. Gillespie, Jonathan French, et al.. (2023). Model‐based meta‐analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus. CPT Pharmacometrics & Systems Pharmacology. 13(2). 281–295. 6 indexed citations
3.
Gillespie, William R., et al.. (2023). Population model‐based analysis of the memory B‐cell response following belimumab therapy in the treatment of systemic lupus erythematosus. CPT Pharmacometrics & Systems Pharmacology. 12(4). 462–473. 4 indexed citations
4.
Gillespie, William R., et al.. (2023). Bayesian PBPK modeling using R/Stan/Torsten and Julia/SciML/Turing.Jl. CPT Pharmacometrics & Systems Pharmacology. 12(3). 300–310. 8 indexed citations
5.
Margossian, Charles C., et al.. (2022). Flexible and efficient Bayesian pharmacometrics modeling using Stan and Torsten, Part I. CPT Pharmacometrics & Systems Pharmacology. 11(9). 1151–1169. 10 indexed citations
6.
Riggs, Matthew M., Leo Seman, Alexander Staab, et al.. (2014). Exposure−response modelling for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes. British Journal of Clinical Pharmacology. 78(6). 1407–1418. 12 indexed citations
7.
8.
Romero, Klaus, Brian Corrigan, Christoffer W. Tornøe, et al.. (2010). Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success. The Journal of Clinical Pharmacology. 50(S9). 9S–19S. 17 indexed citations
9.
10.
Ross, Sue, Adrian Grant, Carl Counsell, et al.. (1999). Barriers to Participation in Randomised Controlled Trials. Journal of Clinical Epidemiology. 52(12). 1143–1156. 712 indexed citations breakdown →
11.
Gillespie, William R., et al.. (1998). Truncated sigmoid Emax model for use with truncated PK/PD aata. Clinical Pharmacology & Therapeutics. 63(2). 199. 5 indexed citations
12.
Gillespie, William R., et al.. (1996). Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding. Journal of Pharmacokinetics and Biopharmaceutics. 24(4). 389–402. 5 indexed citations
13.
Gillespie, William R., et al.. (1994). Mean residence time concepts for non‐linear pharmacokinetic systems. Biopharmaceutics & Drug Disposition. 15(8). 627–641. 7 indexed citations
14.
Gillespie, William R. & Haiyung Cheng. (1993). A Multidimensional Deconvolution Method for Evaluating the Absorption of Drugs Undergoing Reversible Metabolism and Presystemic Metabolite Formation. Journal of Pharmaceutical Sciences. 82(11). 1085–1089. 5 indexed citations
15.
Gillespie, William R., Peter Veng‐Pedersen, Edward J. Antal, & J. Paul Phillips. (1988). A system approach to pharmacodynamics II: Glyburide pharmacodynamics and estimation of optimal drug delivery. Journal of Pharmaceutical Sciences. 77(1). 48–55. 13 indexed citations
16.
Gillespie, William R., P. Veng‐Pedersen, & Thomas Gibson. (1985). Deconvolution applied to the kinetics of extracorporal drug removal. Haemodialysis of cefsulodin. European Journal of Clinical Pharmacology. 29(4). 503–509. 5 indexed citations
17.
Benedetti, T. J., et al.. (1984). Excretion of ibuprofen into breast milk. American Journal of Obstetrics and Gynecology. 149(2). 184–186. 63 indexed citations
18.
Albert, Kenneth S., et al.. (1984). Determination of Flurbiprofen in Human Serum by Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection. Journal of Pharmaceutical Sciences. 73(12). 1823–1825. 34 indexed citations
19.
Wright, Caroline, Edward J. Antal, William R. Gillespie, & Kenneth S. Albert. (1983). Ibuprofen and acetaminophen kinetics when taken concurrently. Clinical Pharmacology & Therapeutics. 34(5). 707–710. 36 indexed citations
20.
Gillespie, William R., et al.. (1982). Relative Bioavailability of Commercially Available Ibuprofen Oral Dosage Forms in Humans. Journal of Pharmaceutical Sciences. 71(9). 1034–1038. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas M. Ludden Breakdown of academic impact, for papers by Mathiéu Molimard Breakdown of academic impact, for papers by G. Russell Warnick Breakdown of academic impact, for papers by James M Wright Breakdown of academic impact, for papers by Graham Jones Breakdown of academic impact, for papers by Stuart Walker Breakdown of academic impact, for papers by Linda M. Thienpont Breakdown of academic impact, for papers by Peter H. Vlasses Breakdown of academic impact, for papers by Richard M. Turner Breakdown of academic impact, for papers by S. George Carruthers
Rankless by CCL
2026